Frontiers in Aging Neuroscience (Sep 2022)

Targeting autonomic nervous system as a biomarker of well-ageing in the prevention of stroke

  • Jean-Claude Barthelemy,
  • Jean-Claude Barthelemy,
  • Vincent Pichot,
  • Vincent Pichot,
  • David Hupin,
  • David Hupin,
  • David Hupin,
  • Mathieu Berger,
  • Mathieu Berger,
  • Mathieu Berger,
  • Sébastien Celle,
  • Sébastien Celle,
  • Lytissia Mouhli,
  • Lytissia Mouhli,
  • Magnus Bäck,
  • Magnus Bäck,
  • Jean-René Lacour,
  • Frederic Roche,
  • Frederic Roche

DOI
https://doi.org/10.3389/fnagi.2022.969352
Journal volume & issue
Vol. 14

Abstract

Read online

Stroke prediction is a key health issue for preventive medicine. Atrial fibrillation (AF) detection is well established and the importance of obstructive sleep apneas (OSA) has emerged in recent years. Although autonomic nervous system (ANS) appears strongly implicated in stroke occurrence, this factor is more rarely considered. However, the consequences of decreased parasympathetic activity explored in large cohort studies through measurement of ANS activity indicate that an ability to improve its activity level and equilibrium may prevent stroke. In support of these observations, a compensatory neurostimulation has already proved beneficial on endothelium function. The available data on stroke predictions from ANS is based on many long-term stroke cohorts. These data underline the need of repeated ANS evaluation for the general population, in a medical environment, and remotely by emerging telemedicine digital tools. This would help uncovering the reasons behind the ANS imbalance that would need to be medically adjusted to decrease the risk of stroke. This ANS unbalance help to draw attention on clinical or non-clinical evidence, disclosing the vascular risk, as ANS activity integrates the cumulated risk from many factors of which most are modifiable, such as metabolic inadaptation in diabetes and obesity, sleep ventilatory disorders, hypertension, inflammation, and lack of physical activity. Treating these factors may determine ANS recovery through the appropriate management of these conditions. Natural aging also decreases ANS activity. ANS recovery will decrease global circulating inflammation, which will reinforce endothelial function and thus protect the vessels and the associated organs. ANS is the whistle-blower of vascular risk and the actor of vascular health. Such as, ANS should be regularly checked to help draw attention on vascular risk and help follow the improvements in response to our interventions. While today prediction of stroke relies on classical cardiovascular risk factors, adding autonomic biomarkers as HRV parameters may significantly increase the prediction of stroke.

Keywords